Skip to main content
×

Reminder – Call for Applications

ESTS WGTS Mid-Career Fellowship in Surgical Oncology

Empowering Women in General Thoracic Surgery

The European Society of Thoracic Surgeons (ESTS) kindly reminds members of the ongoing Call for Applications for the ESTS WGTS Mid-Career Fellowship in Surgical Oncology, an initiative of the Women in Thoracic Surgery Committee.

This fellowship supports women in the first five years after completing training, offering advanced exposure to thoracic oncology research methodology. The programme aims to enable fellows to actively contribute to innovative clinical trials and to the advancement of thoracic cancer care.

Programme Highlights

Duration: 6–12 months

Award: €10,000 to cover travel and accommodation

Location: A leading European academic institution specialising in thoracic oncology trial design and conduct

Focus: Lung cancer research, with emphasis on multidisciplinary care and equitable access

Fellows will benefit from mentorship by academic thoracic surgeons, collaboration with clinician-scientists, and participation in projects integrating laboratory and clinical research.

Eligibility Criteria

Applicants must:

  • Be an ESTS member in good standing (membership invoices paid)

  • Be proficient in English

  • Have completed a general thoracic residency and be actively engaged in cancer research

Preference will be given to applicants from developing countries.

Application Requirements

  • Curriculum vitae and list of publications

  • Motivation letter (maximum 500 words)

  • Proposed research plan and host institution details

  • Acceptance letter from the host institution

  • Recommendation letter from the home institution

  • Detailed budget

Awardees will present their experience and preliminary research results at the ESTS Annual Meeting during the ESTS WGTS networking session.

Application deadline: 30 January 2026
Submission: Please send your complete application to Zlatka Mitreva at zmitreva@kenes.com

This fellowship is kindly supported by AstraZeneca.


View other News Articles

Reminder – Call for Applications image